Skip to search formSkip to main contentSkip to account menu

Certican

National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

everolimus

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
Cardiac allograft vasculopathy compared by intravascular ultrasound sonography: everolimus to mycophenolate mofetil--one single-center experience.
2007
2007
Case report of a kidney transplant recipient converted to everolimus due to malignancy: resolution of bronchiolitis obliterans organizing pneumonia without everolimus discontinuation.
Review
2005
Review
2005
Concentration-Controlled Everolimus (Certican): Combination with Reduced Dose Calcineurin Inhibitors
The calcineurin inhibitors (CNIs) have been the cornerstone of immunosuppressive therapy in recent years, though their… 
2005
2005
Clinical Experience with Everolimus (Certican): A Summary
The calcineurin inhibitors (CNIs) tacrolimus and cyclosporine (CsA) have been the cornerstone of immunosuppressive therapy for… 
2005
2005
Clinical experience with Certican (everolimus) in de novo heart transplant patients at the Deutsches Herzzentrum Berlin.
2005
2005
Clinical experience with Certican (everolimus) in maintenance heart transplant patients at the Medical University of Vienna.
Review
2005
Review
2005
From clinical trials to clinical practice: an overview of Certican (everolimus) in heart transplantation.
Review
2004
Review
2004
Impact of cyclosporine on the development of immunosuppressive therapy.
2001
2001
Efficacy of SDZ RAD compared with CsA monotherapyand combined Rad/FTY720 treatment in a murine cardiac allotransplantation model.
2001
2001
The role of Certican (everolimus, rad) in the many pathways of chronic rejection.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)